Global Metabolomics Industry

Sep 08, 2011, 07:07 ET from Reportlinker

NEW YORK, Sept. 8, 2011 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:

Global Metabolomics Industry

http://www.reportlinker.com/p0611074/Global-Metabolomics-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics

This report analyzes the worldwide markets for Metabolomics in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2008 through 2017. The report profiles 45 companies including many key and niche players such as Agilent Technologies, Inc., Avogadro, BG Medicine, Inc., Biocrates Life Sciences AG, Bio-Rad Laboratories, Inc., Bruker Corporation, Chenomx, Inc., Human Metabolome Technologies, Inc., Metabolon, Inc., Metanomics GmbH, and SiDMAP, LLC. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Data Interpretation & Reporting Level 3

Quantitative Techniques & Analytics 3

Product Definitions and Scope of Study 3

Metabolomics 3

2. INDUSTRY OVERVIEW 4

Outlook 4

Current and Future Analysis 4

Biotechnology and Pharmaceutical Sectors Drive Metabolomics

Research 4

Table 1: World Proteomics Market (2008 & 2015): Percentage

Share Breakdown by Major Product Segments - Mass

Spectrometry, Metabolomics, 2D Gel Electrophoresis and

Differential In-gel Electrophoresis (includes corresponding

Graph/Chart) 5

Metabolomics - A Handy Tool in Drug Discovery 5

Metabolomic Research - A Prospective Tool to Validate

Potential Targets 5

Bioinformatics Segment - Fastest Growing Market Segment 6

Demand for Data Analysis Tools and Software on Rise 6

Groundbreaking Successes to Propel Adoption of Metabolomics 6

Metabolomic Research - A Popular Concept in Europe 7

Food Sciences Look Up to Metabolomics 7

Metabolites Analysis in Biological Specimens Applications 7

Table 2: Global Metabolites Market (2010 & 2014): Percentage

Breakdown of Revenues in Biological Specimens Applications by

Region - North America, Europe, Asia, and Rest of World

(includes corresponding Graph/Chart) 7

Metabolite Profiling for Biomarker Discovery Applications 8

Table 3: Global Metabolite Profiling Market (2010 & 2014):

Percentage Breakdown of Revenues in Biomarker Discovery

Applications by Region - North America, Europe, Asia, and

Rest of World (includes corresponding Graph/Chart) 8

Table 4: Worldwide Oncology Biomarker Discovery Market

(2010): Percentage Share Breakdown by Major Segments-

Genetic, Imaging, Protein and Metabolomics (includes

corresponding Graph/Chart) 8

3. PRODUCT OVERVIEW 9

Metabolomics - Introduction 9

Metabolome 9

Metabolites 9

Metabolomics Vs. Metabonomics 10

Analytical Methods 10

Separation Techniques 10

Gas chromatography 10

Capillary Electrophoresis 10

High Performance Liquid Chromatography (HPLC) 10

Detection Techniques 11

Mass spectrometry 11

Nuclear Magnetic Resonance (NMR) Spectroscopy 11

Surface-based Mass Analysis 11

Key Application Areas 11

Toxicity Assessment/Toxicology 11

Functional Genomics 11

Nutrigenomics 11

Conceptual Approaches in Metabolomics 12

Target Analysis 12

Metabolite Profiling 12

Metabolomics 12

Metabolic Fingerprinting 12

Technological Advancements in Metabolomics 12

Metabolomics as Systems Biology Tool 13

Metabolomics: A Link Between Genetics and Ecology 13

Limitations 14

An Overview of Metabolomics Research 14

Adoption of Metabolomics Research by Type of Entity 14

Implementation of Metabolomics Research by Nature of Study 14

Implementation of Metabolomics Research by Type of Laboratory 14

Key Issues Associated with Metabolomics Study 14

History 15

4. PRODUCT INTRODUCTIONS/INNOVATIONS 16

Food for Health Ireland Launches New Range of Metabolomics 16

BIOCRATES Life Sciences Introduces AbsoluteIDQ p180 Kit 16

BIOCRATES Life Sciences Rolls Out MetaDisIDQ Kit 16

Agilent Technologies Rolls Out GeneSpring GX 11.5 Suite 17

Thermo Fisher Scientific Introduces Version 7.0 of Mass

Frontier Software 18

Thermo Fisher Scientific Rolls Out 'MetQuest' Automated

Metabolic Screening Software 19

Molecular Biometrics Launches ViaMetrics-ET Procedure 19

Bruker Daltonics Introduces First 18 Tesla FTMS Magnet 19

Agilent Technologies Launches 6540 UHD Q-TOF, 7700 Series ICP-

MS and 6430 Triple Quadrupole LC/MS 20

Bio-Rad Introduces Spectral Databases and KnowItAll®

Informatics System 8.1 20

Bio-Rad Laboratories Launches Spectral Databases 20

Agilent Technologies Unveils Agilent 6540 UHD Accurate-mass Q-

TOF LC/MS 21

Genedata Rolls Out Expressionist 5.2 22

Bruker Daltonics Introduces New Ion Trap amaZon Series 22

XenoTech Starts Providing Metabolite Profiling Services 22

5. RECENT INDUSTRY ACTIVITY 24

Bruker Deploys NMR Metabolic Profiling Units Systems 24

OWL Genomics Takes Over Majority Stake in MD Renal 24

Symyx Technologies Inks Partnership with Simulations Plus 24

BIOCRATES Life Sciences Joins SysKid 25

BIOCRATES Life Sciences Signs Agreement with CHENOMX 25

Stemina Biomarker Discovery Teams Up with Agilent Technologies 25

Scottish Metabolomics Facility Selects Mass Spectrometers of

Thermo Fisher Scientific 26

Syngenta Ventures Purchases Stake in Metabolon 26

Horizon Discovery Inks Agreement with GlaxoSmithKline 26

Rexahn Pharmaceuticals Signs Licensing Agreement with Teva

Pharmaceutical Industries 27

Microsoft Takes Over Rosetta Biosoftware 27

Dionex and ESA Biosciences Ink Agreement 27

Agios Pharmaceuticals Discovers New Application of IDH1 Gene

Mutation 28

6. FOCUS ON SELECT PLAYERS 29

Agilent Technologies, Inc. (US) 29

Avogadro (France) 29

BG Medicine, Inc. (US) 29

Biocrates Life Sciences AG (Austria) 30

Bio-Rad Laboratories, Inc. (US) 30

Bruker Corporation (US) 31

Chenomx, Inc. (Canada) 31

Human Metabolome Technologies, Inc. (Japan) 32

Metabolon, Inc. (US) 32

Metanomics GmbH (Germany) 33

SiDMAP, LLC (US) 33

7. GLOBAL MARKET PERSPECTIVE 34

Table 5: World Recent Past, Current and Future Analysis for

Metabolomics by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific (Excluding Japan), and Rest of World Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2008 through 2017 (includes corresponding

Graph/Chart) 34

Table 6: World 10-Year Perspective for Metabolomics by

Geographic Region -Percentage Breakdown of Dollar Revenues for

US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), and

Rest of World Markets for Years 2008, 2011 and 2017 (includes

corresponding Graph/Chart) 35

8. THE UNITED STATES 36

A.Market Analysis 36

Current and Future Analysis 36

Product Introductions/Innovations 36

Recent Industry Activity 42

Key Players 44

B.Market Analytics 47

Table 7: US Recent Past, Current & Future Analysis for

Metabolomics Analyzed with Annual Revenue Figures in US$

Million for Years 2008 through 2017 (includes corresponding

Graph/Chart) 47

9. CANADA 48

A.Market Analysis 48

Current and Future Analysis 48

Key Player 48

B.Market Analytics 49

Table 8: Canadian Recent Past, Current & Future Analysis for

Metabolomics Analyzed with Annual Revenue Figures in US$

Million for Years 2008 through 2017 (includes corresponding

Graph/Chart) 49

10. JAPAN 50

A.Market Analysis 50

Current and Future Analysis 50

Key Player 50

B.Market Analytics 51

Table 9: Japanese Recent Past, Current & Future Analysis for

Metabolomics Analyzed with Annual Revenue Figures in US$

Million for Years 2008 through 2017 (includes corresponding

Graph/Chart) 51

11. EUROPE 52

A.Market Analysis 52

Current and Future Analysis 52

Product Introductions/Innovations 52

Recent Industry Activity 53

B.Market Analytics 54

Table 10: European Recent Past, Current & Future Analysis

for Metabolomics by Geographic Region - France, Germany,

Italy, UK and Rest of Europe Markets Independently Analyzed

with Annual Revenues in US$ Million for Years 2008 through

2017 (includes corresponding Graph/Chart) 54

Table 11: European 10-year Perspective for Metabolomics by

Geographic Region - Percentage Breakdown of Dollar Revenues

for France, Germany, Italy, UK and Rest of Europe Markets

for Years 2008, 2011 and 2017 (includes corresponding

Graph/Chart) 55

11a. FRANCE 56

A.Market Analysis 56

Current and Future Analysis 56

Key Player 56

B.Market Analytics 57

Table 12: French Recent Past, Current & Future Analysis for

Metabolomics Independently Analyzed with Annual Revenues in

US$ Million for Years 2008 through 2017 (includes

corresponding Graph/Chart) 57

11b. GERMANY 58

A.Market Analysis 58

Current and Future Analysis 58

Key Player 58

B.Market Analytics 59

Table 13: German Recent Past, Current & Future Analysis for

Metabolomics Independently Analyzed with Annual Revenues in

US$ Million for Years 2008 through 2017 (includes

corresponding Graph/Chart) 59

11c. ITALY 60

A.Market Analysis 60

Current and Future Analysis 60

B.Market Analytics 60

Table 14: Italian Recent Past, Current & Future Analysis for

Metabolomics Independently Analyzed with Annual Revenues in

US$ Million for Years 2008 through 2017 (includes

corresponding Graph/Chart) 60

11d. THE UNITED KINGDOM 61

A.Market Analysis 61

Current and Future Analysis 61

B.Market Analytics 61

Table 15: UK Recent Past, Current & Future Analysis for

Metabolomics Independently Analyzed with Annual Revenues in

US$ Million for Years 2008 through 2017 (includes

corresponding Graph/Chart) 61

11e. REST OF EUROPE 62

A.Market Analysis 62

Current and Future Analysis 62

Product Introductions/Innovations 62

Recent Industry Activity 63

Key Player 64

B.Market Analytics 65

Table 16: Rest of Europe Recent Past, Current & Future

Analysis for Metabolomics Independently Analyzed with Annual

Revenues in US$ Million for Years 2008 through 2017

(includes corresponding Graph/Chart) 65

12. ASIA-PACIFIC 66

A.Market Analysis 66

Current and Future Analysis 66

B.Market Analytics 66

Table 17: Asia-Pacific Recent Past, Current & Future

Analysis for Metabolomics Analyzed with Annual Revenue

Figures in US$ Million for Years 2008 through 2017 (includes

corresponding Graph/Chart) 66

13. REST OF WORLD 67

A.Market Analysis 67

Current and Future Analysis 67

B.Market Analytics 67

Table 18: Rest of World Recent Past, Current & Future

Analysis for Metabolomics Analyzed with Annual Revenue

Figures in US$ Million for Years 2008 through 2017 (includes

corresponding Graph/Chart) 67

COMPETITIVE LANDSCAPE

Total Companies Profiled: 45 (including Divisions/Subsidiaries - 49)

------------------------------------------

Region/Country Players

------------------------------------------

The United States 27

Canada 3

Japan 2

Europe 14

France 1

Germany 3

The United Kingdom 1

Italy 1

Spain 2

Rest of Europe 6

Asia-Pacific (Excluding Japan) 3

------------------------------------------

To order this report:

Genomics Industry: Global Metabolomics Industry

Genomics Business News

More  Market Research Report

Check our  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com